Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia.
Cricopharyngeal achalasia produces dysphagia in many patients. The spasm has been treated in the past with medication, bouginage, pharyngeal plexus neurectomy, and cricopharyngeal myotomy. In some patients the cause of dysphagia may be elusive, or the patient may be a poor risk for a surgical intervention. We have found that cricopharyngeal muscle injections of botulinum toxin can be useful in the diagnosis and therapy of cricopharyngeal spasm.
Blitzer
A
A
New York Center for Voice and Swallowing Disorders and the Head and Neck Surgical Group, Mt. Sinai Medical Center, New York, New York 10019, USA.
Brin
M F
MF
D000368:Aged; D001905:Botulinum Toxins / Q000008:administration & dosage* / Q000627:therapeutic use; D003680:Deglutition Disorders / Q000209:etiology; D004931:Esophageal Achalasia / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged
D001905:Botulinum Toxins